Select Medical Holdings Yönetim

Yönetim kriter kontrolleri 2/4

Select Medical Holdings CEO'su David Chernow, Jan2014 tarihinde atandı, in görev süresi 11.33 yıldır. in toplam yıllık tazminatı $ 10.31M olup, şirket hissesi ve opsiyonları dahil olmak üzere 9.6% maaş ve 90.4% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.54% ine doğrudan sahiptir ve bu hisseler € 9.32M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1.6 yıl ve 15.8 yıldır.

Anahtar bilgiler

David Chernow

İcra Kurulu Başkanı

US$10.3m

Toplam tazminat

CEO maaş yüzdesi	9.65%
CEO görev süresi	11.3yrs
CEO sahipliği	0.5%
Yönetim ortalama görev süresi	1.6yrs
Yönetim Kurulu ortalama görev süresi	15.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

David Chernow'un ücretlendirmesi Select Medical Holdings'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Mar 31 2025	n/a	n/a	US$61m
Dec 31 2024	US$10m	US$995k	US$45m
Sep 30 2024	n/a	n/a	US$30m
Jun 30 2024	n/a	n/a	US$23m
Mar 31 2024	n/a	n/a	US$24m
Dec 31 2023	US$11m	US$995k	US$52m
Sep 30 2023	n/a	n/a	US$217m
Jun 30 2023	n/a	n/a	US$196m
Mar 31 2023	n/a	n/a	US$174m
Dec 31 2022	US$9m	US$995k	-US$20m
Sep 30 2022	n/a	n/a	US$175m
Jun 30 2022	n/a	n/a	US$223m
Mar 31 2022	n/a	n/a	US$329m
Dec 31 2021	US$12m	US$995k	US$389m
Sep 30 2021	n/a	n/a	US$415m
Jun 30 2021	n/a	n/a	US$415m
Mar 31 2021	n/a	n/a	US$306m
Dec 31 2020	US$8m	US$995k	US$250m
Sep 30 2020	n/a	n/a	US$206m
Jun 30 2020	n/a	n/a	US$162m
Mar 31 2020	n/a	n/a	US$155m
Dec 31 2019	US$8m	US$995k	US$143m
Sep 30 2019	n/a	n/a	US$136m
Jun 30 2019	n/a	n/a	US$138m
Mar 31 2019	n/a	n/a	US$140m
Dec 31 2018	US$8m	US$995k	US$133m

Tazminat ve Piyasa: David 'nin toplam tazminatı ($USD 10.31M ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.85M ).

Tazminat ve Kazançlar: David 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

David Chernow (67 yo)

11.3yrs

Görev süresi

US$10,311,733

Tazminat

Mr. David S. Chernow serves as Director at Exokinetics, Inc. He has been the Chief Executive Officer at Select Medical Holdings Corporation and serves as its Director from August 01, 2024 and at Select Med...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Robert Ortenzio	Co-Founder & Executive Chairman	20.3yrs	US$10.34m	6.96% € 120.6m
David Chernow	Director & CEO	11.3yrs	US$10.31m	0.54% € 9.3m
Thomas Mullin	Co-President	1.6yrs	US$4.84m	0.24% € 4.2m
Michael Malatesta	Executive VP & CFO	1.6yrs	US$3.95m	0.13% € 2.3m
Martin Jackson	Senior Executive Vice President of Strategic Finance & Operations	1.6yrs	US$6.20m	0.99% € 17.2m
John Saich	Co-President	1.6yrs	Veri yok	0.51% € 8.9m
Christopher Weigl	Senior VP	2.2yrs	Veri yok	0.027% € 461.6k
Brian Rusignuolo	Executive VP & Chief Information Officer	4.3yrs	Veri yok	0.23% € 4.1m
Michael Tarvin	Senior Executive VP	28.3yrs	US$4.44m	0.33% € 5.8m
Robert Breighner	Senior Vice President of Compliance & Audit	no data	Veri yok	0.028% € 485.5k
Bridget Sherick	Senior Vice President of Accounting for Shared Services	1.6yrs	Veri yok	Veri yok
John Duggan	Executive VP & Deputy General Counsel	1.6yrs	Veri yok	Veri yok

1.6yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: S24 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.6 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Robert Ortenzio	Co-Founder & Executive Chairman	20.3yrs	US$10.34m	6.96% € 120.6m
David Chernow	Director & CEO	19.8yrs	US$10.31m	0.54% € 9.3m
Russell Carson	Independent Lead Director	20.3yrs	US$85.70k	0.85% € 14.8m
Thomas Scully	Independent Director	21.3yrs	US$88.00k	0.070% € 1.2m
Daniel Thomas	Independent Director	5.8yrs	US$108.60k	0.051% € 889.4k
William Frist	Independent Director	15yrs	US$109.89k	0.22% € 3.9m
Marilyn Tavenner	Independent Director	6.5yrs	US$98.60k	0.017% € 296.5k
James Ely	Independent Director	16.5yrs	US$116.60k	0.11% € 2.0m
Katherine Davisson	Independent Director	4.1yrs	US$110.60k	0.036% € 619.9k
Parvinderjit Khanuja	Independent Director	3.5yrs	US$107.49k	0.051% € 877.1k

15.8yrs

Ortalama Görev Süresi

66yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: S24 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 15.8 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/05/20 00:30
Gün Sonu Hisse Fiyatı	2025/05/20 00:00
Kazançlar	2025/03/31
Yıllık Kazançlar	2024/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Select Medical Holdings Corporation 18 Bu analistlerden 5, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Brian Williams	Avondale Partners
Benjamin Mayo	Baird
William Sutherland	Benchmark Company

Select Medical Holdings Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Select Medical Holdings Corporation, Annual General Meeting, Apr 24, 2025

Insufficient new directors

Insufficient new directors

Select Medical Holdings Corporation, Annual General Meeting, Apr 25, 2024

Select Medical Holdings Corporation Announces Appointment of Michael Malatesta as Chief Financial Officer, Effective October 1, 2023

Insider recently sold €268k worth of stock

Recent updates

Select Medical Holdings Corporation Provides Earnings Guidance for the Year 2025

Select Medical Holdings Corporation to Report Q1, 2025 Results on May 01, 2025

Select Medical Holdings Corporation, Annual General Meeting, Apr 24, 2025

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About March 13, 2025

Select Medical Holdings Corporation Provides Earnings Guidance for the Year Ending December 31, 2025

Select Medical Holdings Corporation to Report Q4, 2024 Results on Feb 20, 2025

Select Medical Holdings Corporation completed the Spin-Off of Concentra Group Holdings, LLC.

Insufficient new directors

Investor sentiment improves as stock rises 16%

Third quarter dividend of US$0.13 announced

Third quarter 2024 earnings released: EPS: US$0.43 (vs US$0.38 in 3Q 2023)

Select Medical Holdings Corporation Updates Earnings Guidance for the Year Ending December 31, 2024

Select Medical Holdings Corporation to Report Q3, 2024 Results on Oct 31, 2024

New major risk - Revenue and earnings growth

Second quarter dividend of US$0.13 announced

Second quarter 2024 earnings released: EPS: US$0.60 (vs US$0.61 in 2Q 2023)

Select Medical Holdings Corporation Declares a Cash Dividend, Payable on or About August 30, 2024

Select Medical Holdings Corporation to Report Q2, 2024 Results on Aug 01, 2024

Investor sentiment improves as stock rises 18%

First quarter dividend of US$0.13 announced

New minor risk - Shareholder dilution

First quarter 2024 earnings released: EPS: US$0.75 (vs US$0.56 in 1Q 2023)

Select Medical Reaffirms Earnings Guidance for the Year 2024

Insufficient new directors

Select Medical Holdings Corporation to Report Q1, 2024 Results on May 02, 2024

Select Medical Holdings Corporation, Annual General Meeting, Apr 25, 2024

Fourth quarter dividend of US$0.13 announced

Full year 2023 earnings released: EPS: US$1.91 (vs US$1.23 in FY 2022)

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About March 13, 2024

Select Medical Holdings Corporation to Report Q4, 2023 Results on Feb 22, 2024

Upcoming dividend of US$0.13 per share at 2.3% yield

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About November 28, 2023

Third quarter 2023 earnings released: EPS: US$0.38 (vs US$0.21 in 3Q 2022)

Select Medical Holdings Corporation to Report Q3, 2023 Results on Nov 02, 2023

Select Medical Holdings Corporation Announces Appointment of Michael Malatesta as Chief Financial Officer, Effective October 1, 2023

Select Medical Holdings Corporation Announces Cash Dividend, Payable on or about September 1, 2023

Second quarter 2023 earnings released: EPS: US$0.61 (vs US$0.43 in 2Q 2022)

Select Medical Holdings Corporation Provides Earnings Guidance for the Second Quarter Ended June 30, 2023

Select Medical Holdings Corporation to Report Q2, 2023 Results on Aug 03, 2023

Select Medical Holdings Corporation(NYSE:SEM) dropped from Russell Small Cap Comp Value Index

Insider recently sold €268k worth of stock

Upcoming dividend of US$0.13 per share at 1.7% yield

Select Medical Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of 2023

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About May 31, 2023

First quarter 2023 earnings released: EPS: US$0.56 (vs US$0.37 in 1Q 2022)

Full year 2022 earnings released: EPS: US$1.23 (vs US$2.99 in FY 2021)

Select Medical Holdings Corporation to Report Q4, 2022 Results on Feb 23, 2023

Investor sentiment improved over the past week

Upcoming dividend of US$0.13 per share

Third quarter 2022 earnings released: EPS: US$0.21 (vs US$0.57 in 3Q 2021)

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About November 29, 2022

Select Medical Holdings Corporation to Report Q3, 2022 Results on Nov 03, 2022

Now 21% undervalued

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About September 2, 2022

Now 24% undervalued

Second quarter 2022 earnings released: EPS: US$0.43 (vs US$1.22 in 2Q 2021)

Select Medical Holdings Corporation to Report Q2, 2022 Results on Aug 04, 2022

Upcoming dividend of US$0.13 per share

First quarter 2022 earnings released: EPS: US$0.37 (vs US$0.82 in 1Q 2021)

Select Medical Holdings Corporation Announces Cash Dividend, Payable on or About June 1, 2022

Select Medical Holdings Corporation to Report Q1, 2022 Results on May 05, 2022

Select Medical Holdings Corporation (NYSE:SEM) acquired Six Critical Illness Recovery Hospitals.

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Select Medical Holdings Corporation Provides Revenue Guidance for the Year 2022

Investor sentiment deteriorated over the past week

Select Medical Holdings Corporation Provides Earnings Guidance for the Year Ended December 31, 2021

Third quarter 2021 earnings released: EPS US$0.57 (vs US$0.57 in 3Q 2020)

Independent Director recently sold €308k worth of stock

Upcoming dividend of US$0.13 per share